title: Malignant melanoma amongst Maori and New Zealand Europeans, 2000-2004.
abstract: BACKGROUND
  Although cutaneous melanoma (CM) is rare among dark-skinned populations, it has been found that dark-skinned patients diagnosed with CM tend to have greater Breslow thickness and therefore a worse prognosis.
  
  
  METHODS
  Data was obtained from the New Zealand Cancer Registry pertaining to CM ICD-10 codes from 2000 to 2004. This data was used to compare different ethnicities. We compared New Zealand Europeans with those identifying themselves as Maori. Incorrect or absent data, benign nevi, and melanoma in situ were all excluded from analysis. Only one data entry was accepted per patient to avoid the inclusion of metastases.
  
  
  RESULTS
  Overall, 9004 patients were registered as being diagnosed with CM during 2000-2004, and 7120 with complete ethnicity data were analyzed. A total of 69 cases were identified as Maori. The incidence of CM among Maori is 2.7 per 100,000. Maori had significantly greater Breslow thickness compared with New Zealand Europeans (1.3 vs. 0.80 mm, P < 0.0001). There were differences in type of CM between the two groups (P < 0.00001); in particular, Maori had more acral CM (2.9% vs. 0.8%).
  
  
  CONCLUSIONS
  Cutaneous melanoma is much less common among Maori than among New Zealand Europeans, but Maori have a greater Breslow depth and therefore have a worse prognosis. Increased awareness on behalf of these groups and health care practitioners should assist in ensuring early detection, thereby improving the overall outcome in Maori.
authors.affiliation: Department of General Surgery, North Shore Hospital, Auckland, New Zealand. toddnz@gmail.com
authors.forename: Todd
authors.initials: T
authors.lastname: Hore
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Robinson
authors.forename: Richard C W
authors.initials: RC
authors.lastname: Martin
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005006:Ethnicity; D005060:Europe / Q000208:ethnology; D005260:Female; D006801:Humans; D015994:Incidence; D016014:Linear Models; D008297:Male; D008545:Melanoma / Q000453:epidemiology / Q000208:ethnology* / Q000473:pathology; D008875:Middle Aged; D009520:New Zealand / Q000453:epidemiology / Q000208:ethnology; D011379:Prognosis; D012042:Registries; D012878:Skin Neoplasms / Q000453:epidemiology / Q000208:ethnology* / Q000473:pathology
references.citation: Cancer Causes Control. 2003 Mar;14(2):109-21
references.pmid: 12749716
references.citation: Cancer Causes Control. 1997 Mar;8(2):246-52
references.pmid: 9134249
references.citation: J Clin Oncol. 2001 Aug 15;19(16):3622-34
references.pmid: 11504744
references.citation: Pac Health Dialog. 2002 Mar;9(1):40-7
references.pmid: 12737416
references.citation: N Z Med J. 2008 Aug 08;121(1279):18-26
references.pmid: 18709044
references.citation: J Clin Oncol. 2001 Aug 15;19(16):3635-48
references.pmid: 11504745
references.citation: Cancer Causes Control. 2006 Feb;17(1):21-7
references.pmid: 16411049
references.citation: J Clin Oncol. 2008 Jan 1;26(1):66-75
references.pmid: 18165642
references.citation: ANZ J Surg. 2004 Apr;74(4):233-7
references.pmid: 15043734
references.citation: J Am Acad Dermatol. 2004 Jan;50(1):21-4; discussion 142-3
references.pmid: 14699360
references.citation: J Am Acad Dermatol. 1993 Jun;28(6):1008-11
references.pmid: 8496443
references.citation: Int J Cancer. 1990 Apr 15;45(4):691-3
references.pmid: 2323847
references.citation: Cancer. 1995 Jan 15;75(2 Suppl):667-73
references.pmid: 7804993